Next Article in Journal
Influence of ZSM-5 Crystal Size on Methanol-to-Olefin (MTO) vs. Ethanol-to-Aromatics (ETA) Conversion
Next Article in Special Issue
Quercetin, a Flavonoid with Great Pharmacological Capacity
Previous Article in Journal
Bioactive Components of Lycium barbarum and Deep-Processing Fermentation Products
Previous Article in Special Issue
A Comprehensive Review of Natural Flavonoids with Anti-SARS-CoV-2 Activity
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 28
Issue 24
10.3390/molecules28248045
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Medicinal Herbs: Promising Immunomodulators for the Treatment of Infectious Diseases

by
Hamad H. Alanazi
*,
Abdelbaset Mohamed Elasbali
,
Maged K. Alanazi
and
Eman Fawzy El Azab
Department of Clinical Laboratory Science, College of Applied Medical Sciences-Qurayyat, Jouf University, Al-Qurayyat 77455, Saudi Arabia
*
Author to whom correspondence should be addressed.
Molecules 2023, 28(24), 8045; https://doi.org/10.3390/molecules28248045
Submission received: 2 October 2023 / Revised: 10 November 2023 / Accepted: 15 November 2023 / Published: 12 December 2023
(This article belongs to the Special Issue Innovative Therapeutic Applications of Natural Compounds and Nature-Inspired Small Molecules)
Browse Figure
Versions Notes

Abstract

:
Humans are constantly at high risk of emerging pandemics caused by viral and bacterial infections. The emergence of new pandemics is mainly caused by evolved viruses and bacteria that are highly resistant to existing medications. The rapid evolution of infectious agents demands the urgent investigation of new therapeutic strategies to prevent and treat these infections at an early stage. One of these therapeutic strategies includes the use of medicinal herbs for their antibacterial and antiviral properties. The use of herbal medicines as remedies is very ancient and has been employed for centuries. Many studies have confirmed the antimicrobial activities of herbs against various pathogens in vitro and in vivo. The therapeutic effect of medicinal herbs is mainly attributed to the natural bioactive molecules present in these plants such as alkaloids, flavonoids, and terpenoids. Different mechanisms have been proposed for how medicinal herbs enhance the immune system and combat pathogens. Such mechanisms include the disruption of bacterial cell membranes, suppression of protein synthesis, and limitation of pathogen replication through the inhibition of nucleic acid synthesis. Medicinal herbs have been shown to treat a number of infectious diseases by modulating the immune system’s components. For instance, many medicinal herbs alleviate inflammation by reducing pro-inflammatory cytokines (e.g., tumor necrosis factor-alpha (TNF-α), interleukin-1, IL-6) while promoting the production of anti-inflammatory cytokines (e.g., IL-10). Medicinal herbs also play a role in defense against viral and intracellular infections by enhancing the proliferation and functions of natural killer cells, T-helper-1 cells, and macrophages. In this review, we will explore the use of the most common herbs in preventing and treating infectious and non-infectious diseases. Using current and recently published studies, we focus on the immunomodulatory and therapeutic effects induced by medicinal herbs to enhance immune responses during diseases.

1. Introduction

1.1. Immunomodulatory Effects of Innate and Adaptive Immune Systems

The immune system is the main barrier against harmful invaders like viruses, bacteria, and fungi. It comprises many organs, tissues, proteins, and cells including bone marrow, thymus, spleen, complement proteins, and leukocytes. Each of these components has a specific role in forming immunity against foreign invaders. The bone marrow is where almost all blood cells originate (e.g., dendritic cells, B-cells), and the thymus is the place for the maturation of T-cells. The immune system has two parts: innate and adaptive. The innate immune system is the first line of defense against foreign invaders. It consists of physical, biological, and chemical barriers that ensure the elimination of pathogens. Innate immune cells such as macrophages, dendritic cells, and natural killer cells (NK) can recognize and respond to foreign pathogens through pattern recognition receptors (PRRs) found in the endosome or on the cell membrane [1]. The recognition of microbial particles by PRRs leads to their activation and thus the release of cytokines and chemokines which promote inflammation and recruit other immune cells (such as neutrophils) to the site of the infection [1]. Moreover, innate immune cells can phagocytose and eliminate pathogens directly. For instance, many neutrophils phagocytose bacteria during bacterial infections and destroy them through enzymatic activities by forming reactive oxygen species (ROS), such as superoxide radicals, and hydrogen peroxide [2]. When the innate immune system fails to clear the pathogen, the adaptive immune system steps in to stop the infection. At this stage, the innate immune system regulates adaptive immune responses by presenting antigens to T-cells through dendritic cells and macrophages and producing cytokines that enhance T- and B-cell differentiation and proliferation [3].
In the case of intracellular infections caused by viruses or bacteria, natural killer cells and phagocytes such as macrophages destroy infected cells and engulf the pathogen, respectively. Infected cells then produce cytokines such as interferons which interfere with pathogen replication inside the host cells and recruit other immune cells to the site of infection [4]. Importantly, when natural killer cells and phagocytes fail to seize the intracellular infections, these cells present small fragments of the foreign antigen on the cell surface through a molecule called major histocompatibility complex-I (MHC-I). This way, the adaptive immune cells (i.e., CD8 or cytotoxic T-cells) are now alerted to an intracellular invader. Once cytotoxic T-cells are fully activated, they kill the infected cells with cytotoxic proteins called granzymes and perforins [5].
During extracellular infections by agents like bacteria or parasites, complement proteins and phagocytes including neutrophils destroy the pathogen [1]. However, when innate immunity fails, antigen-presenting cells such as dendritic cells phagocytose the pathogen and migrate to secondary lymphoid organs such as the lymph nodes. There, they present antigenic peptides through MHC-II to T-helper cells which aid B-cells in the production of antibodies [6]. Antibodies are highly efficient in combating extracellular agents through neutralization, blocking, and facilitating the process of phagocytosis [7].
In some cases, the immune system induces weak or insufficient immune responses towards pathogens and thus requires immunomodulators. Immunomodulators have been shown to be very therapeutically useful in the context of numerous diseases such as autoimmune diseases, cancers, and microbial infections [8,9]. In addition, immunomodulators have also been tested in reducing or suppressing overactive immune responses [10]. There are different types of immunomodulators that work as immunosuppressants, such as cyclosporine and tacrolimus which act by inhibiting T-cell activation in autoimmune diseases like rheumatoid arthritis and lupus [11,12]. However, many immunomodulators called immunostimulants act by enhancing immune responses during microbial infections or tumors. These include interferons, which enhance the functions of NK cells, and interleukins, which promote the proliferation and differentiation of T- and B-cells during disease [13].
Several studies have shown that phytochemicals or plant-derived compounds have beneficial immunomodulatory effects (Table 1). We have specifically selected these medicinal herbs because of their well-documented therapeutic properties. People have been using herbs as treatments for thousands of years [14]. In experimental studies, some of these herbs have been proven to be effective in treating disease in animal models and clinical settings (Figure 1). However, the mechanisms of how these natural compounds work are not clear. Several important bioactive compounds are commonly found in herbs that produce similar effects. In this review, we focus on defining the main bioactive components in common phytochemicals and which of these components are shared with other phytochemicals, as well as how these components modulate immune responses therapeutically.

1.2. Examples of Therapeutically Important Medicinal Herbs

1.2.1. Ashwagandha (Withania somnifera)

Ashwagandha (Withania somnifera) is a medicinal herb that has been used for ages to treat various medical conditions like anxiety, stress, diabetes, epilepsy, arthritis, and many inflammatory diseases [45,46]. W. somnifera’s bioactive components such as alkaloids and withanolides induce several immunomodulatory effects that enhance the immune system. It increases the proliferation and activity of T-cells, natural killer cells, and macrophages [15]. W. somnifera also induces anti-inflammatory effects and reduces pro-inflammatory effects through modulating cytokines such as IL-4 [15]. Studies testing the immunomodulatory role of W. somnifera in vivo resulted in very promising therapeutic effects. In a study using APP/PS1 transgenic mice as a model for Alzheimer’s disease, oral administration of W. somnifera semi-purified extract for 30 days reversed the phenotypes of Alzheimer’s disease such as behavioral impairments, plaque development, and the buildup of beta-amyloid peptides (Aβ) and oligomers in the brains of middle-aged and elderly APP/PS1 transgenic mice [47]. In cancer studies, W. somnifera was shown to be a highly effective treatment in vitro and in vivo. The study suggested that W. somnifera induces its antitumor activities by generating ROS and inducing apoptosis in new cancer cells while tolerating normal cells [48]. Moreover, W. somnifera was shown to promote chemotherapy through the enhancement of mitochondrial dysfunction in cancerous cells only [49]. W. somnifera was also tested for its therapeutic value in metabolic diseases like diabetes. It was shown that W. somnifera can restore urine sugar, blood glucose, and glycosylated hemoglobin (HbA1C) in rat diabetic models (alloxan-induced diabetes mellitus (DM) rats) [50]. Additionally, W. somnifera also plays a therapeutic role in inflammation and chronic diseases like arthritis. A study by khan et al. showed that the oral administration of W. somnifera root at a dose of 300 mg/kg reduces the inflammatory cytokines (e.g., TNF-α, IL-1β, IL-6) which are usually high in arthritic rats [51]. The study also showed that W. somnifera root induces an increase in anti-inflammatory cytokines (i.e., IL-10) and the suppression of NF-κB, which is an important transcription factor for inflammation [51]. These findings suggest a great therapeutic role for W. somnifera in the treatment of inflammatory diseases like arthritis.

1.2.2. Astragalus (Astragalus membranaceus)

Astragalus (Astragalus membranaceus) is a traditional Chinese medicinal herb that has been used for centuries to treat a variety of diseases. A. membranaceous has many anti-inflammatory, antioxidant, and immunoregulatory effects [52]. The main components of A. membranaceous are polysaccharides, flavonoids, and saponins. Additionally, astragalus has been used for its antitumor activities as in vivo studies demonstrated elevated levels of natural killer (NK) cells and NK-derived interferon-γ (IFN-γ) after the administration of astragalus [18]. The A. membranaceous component polysaccharide increases T-helper (Th1) cell numbers [53]. It seems that astragalus polysaccharide (APS) is the main active component in A. membranaceous. Many studies investigated the role of APS in several chronic diseases. It was shown that APS has a protective role in diseases like diabetes, renal injuries, and myocardial dysfunction [54,55,56]. In addition to APS, the A. membranaceous component astragaloside IV has also been shown to modulate immune responses by increasing both cellular and humoral immunity. Astragaloside IV increases T- and B-cell proliferation, antibody production, and anti-inflammatory cytokines such as transforming growth factor-β (TGF-β), but reduces pro-inflammatory cytokines such as TNF-α and IL-1 [57,58].
In vivo studies testing the therapeutic immunomodulatory role of A. membranaceous have shown promising results. The A. membranaceous component astragalus polysaccharides (APS) improved immunity and reversed immunosuppression and microbial dysbiosis [59]. Moreover, the A. membranaceous chemical component astragaloside IV (as-IV) was shown to attenuate myocardial ischemia–reperfusion injury in rats by regulating the PI3K/AKT/GSK-3β signaling pathways, thereby improving cardiovascular health [60]. The therapeutic effects of A. membranaceous extended to chronic diseases like diabetic nephropathy and kidney dysfunction [61,62]. It was noted that blood pressure and urinary albumin were drastically reduced in chronic kidney disease (CKD) rat models treated with A. membranaceous compared to CKD rats that were untreated [62]. Moreover, A. membranaceous extract was shown to suppress the proliferation of breast cancer cells via the PI3K/AKT/mTOR signaling pathway, suggesting an alternative antitumor strategy [63]. The A. membranaceous-extracted polysaccharide called PG2 was reported to suppress the expression of programmed cell death protein ligand 1 (PD-L1), which contributes to cancer immunotherapy; thereby, this could be used as an effective approach when combined with other treatments [64].

1.2.3. Echinacea (Echinacea purpurea)

Echinacea purpurea (E. purpurea) is a medicinal herb that has been used for centuries to treat a number of diseases like cold and flu. E. purpurea has multiple therapeutic properties including immunomodulatory, anti-inflammatory, antibacterial, and antiviral effects. The beneficial effects of E. purpurea are attributed to its main bioactive components including alkamides, caffeic acid derivatives, and polysaccharides [65]. Both cellular and humoral immunity were enhanced by E. purpurea [66]. Studies also showed that T- and B-lymphocytes as well as NK cell proliferation and activity were increased following E. purpurea extract treatment [67]. In vivo experiments have suggested that E. purpurea extract has several immunomodulatory effects [67]. The oral administration of E. purpurea extract in a mouse model was shown to elevate MHC II and increase several immune components such as CD4+ T-cells, Th1 cytokines, and immunoglobulin levels [67]. In addition to the role of E. purpurea in immunomodulation, it was shown that E. purpurea extract can reduce inflammation markers in vitro and in vivo through signaling pathways involving ERK1/2, p38, STAT3, and cyclooxygenase-2 (COX-2) [68,69]. Moreover, the therapeutic activity of E. purpurea extract was tested for wound healing. In a model wounds of HaCaT cells, it was reported that E. purpurea extract promoted significant wound healing, demonstrated by the migration of keratinocytes and fibroblasts to the wound (scratch in cell monolayer) [70]. E. purpurea extract is also efficient in treating chronic disorders such as diabetes mellitus (DM) [71]. Additionally, it was reported in this study that the administration of E. purpurea extract for about 4 weeks significantly improved hyperglycemia and insulin resistance in a diabetic rat model [71]. Furthermore, E. purpurea extract improved other medical conditions usually linked with diabetes and oxidative stress leading to infertility. It was shown that E. purpurea extract preserved sperm motility, sperm morphology, and mitochondrial membrane potential [71].

1.2.4. Garlic (Allium sativum)

Garlic (Allium sativum) is a very common natural product used for culinary and healing purposes. A. sativum has been shown to treat bacterial, fungal, and viral infections [72]. Many of the therapeutic effects of A. sativum are attributed to a substance called “Allicin” which is the major natural sulfur compound released when garlic is crushed [72]. A. sativum has been used as a therapeutic in a number of chronic medical conditions. In cardiovascular diseases, it reduces cholesterol levels and high blood pressure, and it has been shown to have many immunomodulatory effects [73]. As an immunomodulator, A. sativum was shown to inhibit inflammation by suppressing IL-6, MCP-1, TNF-α, and NF-κB activity [23]. A. sativum was shown to have antiviral activity; for instance, A. sativum defends against human immunodeficiency virus (HIV) by inhibiting virus adhesion to host cells [74]. It also possesses antiviral activities against other viruses such as SARS-CoV-2, herpes simplex virus (HSV)-1 and -2, and others [74].
Allium sativum has been shown to have a huge impact on diabetic patients by improving insulin sensitivity and regulating blood glucose [75]. It has robust inhibitory activities against both Gram-positive and Gram-negative bacteria [76]. As a result of using antibiotics, many bacterial strains develop resistance to different antibiotics, such as the case of certain resistant strains of Clostridium perfringens and Escherichia coli, which cannot be killed by penicillin but are sensitive to garlic [77]. These data support the presence of the immunomodulatory effects of garlic on infections. In addition to the role of A. sativum in microbial diseases, some studies also showed that its therapeutic effects extend to different types of cancer. It was shown that A. sativum seizes the proliferation of cancer cells and stops the metastasis of the tumors by promoting the apoptosis of cancer cells [78]. Moreover, allcian, which is the main bioactive compound in A. sativum, was shown to suppress angiogenesis, thus promoting tumor regression [79].

1.2.5. Ginger (Zingiber officinale)

Ginger (Zingiber officinale) has been used to treat diseases or alleviate inflammation for many years. The main bioactive components in Z. officinale are gingerols and shogaols, which promote anti-inflammatory and antioxidant immunomodulatory effects [80]. Z. officinale reduces the symptoms of inflammation and certain diseases through a number of immunomodulatory effects such as negatively modulating pro-inflammatory cytokines (e.g., TNF-α, IL-1β, and IL-6) while increasing anti-inflammatory cytokines such as IL-10 [30,81]. Z. officinale also has antiviral and antibacterial properties that can help treat various microbial infections [82]. In the case of viral infections where Th1 cells and interferons play an important role, ginger increases the proliferation and activation of Th1 cells and the production of IFN-γ cytokines, which are important for defense against infections caused by intracellular pathogens [83]. The effects of Z. officinale extend to B-cells. Zingiber officinale is known to promote the production of antibodies such as IgG and IgA by B-cells [84].
Zingiber officinale has been used in the treatment of various medical conditions like osteoarthritis, as well as joint and muscle discomfort, and neurological conditions [85]. It has also been used as a treatment for toothaches, asthma, diabetes, and constipation [85]. In diabetic patients, the oral administration of Z. officinale modulates various biological markers such as fasting blood sugar levels, hemoglobin A1c levels, apolipoprotein B, and apolipoprotein A-I [86]. In cancer studies, it was shown that Z. officinale stimulates apoptosis in multiple cancer types including ovarian, colon, breast, cervical, and prostate cancer [87]. Overall, ginger promotes several therapeutic benefits in a number of diseases and cancer forms; however, clinical trials to test its efficacy in treating and preventing cancer are still ongoing.

1.2.6. Ginseng (Panax ginseng)

Ginseng (Panax ginseng) is a very common herb used for the treatment of numerous diseases such as high blood pressure, cancer, cardiovascular diseases, and hepatitis C [88,89]. P. ginseng has anti-inflammatory, antioxidant, and antitumor properties [90]. Similar to Z. officinale, P. ginseng promotes several immunomodulatory effects through immune system components. It was shown to enhance the production of anti-inflammatory cytokines (e.g., IL-10) and suppress the production of pro-inflammatory cytokines like TNF-α, IL-1β, IL-1, and IL-6 [91,92]. P. ginseng was also shown to enhance the proliferation and activation of lymphocytes including T-cells, B-cells, and NK cells, and the production of different subsets of immunoglobulins [93,94].

1.2.7. Licorice (Glycyrrhiza glabra)

Licorice (Glycyrrhiza glabra) has been used as a traditional medicine to treat a wide range of diseases, including respiratory disorders, gastrointestinal disorders, skin conditions, and inflammatory diseases [95,96,97]. The main bioactive compounds in G. glabra are flavonoids, triterpenoids, and saponins which are believed to be responsible for the anti-inflammatory, antioxidant, antiviral, and immunomodulatory effects of G. glabra [98,99]. G. glabra was shown to have anti-inflammatory features. It suppresses pro-inflammatory cytokines, such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) [98]. G. glabra was also shown to enhance the immune system against viral infections [100]. It increases T-cell activation and promotes T-regulatory cells (Treg). NK cell activity was enhanced by G. glabra, which plays a vital role in defense against viruses and cancerous cells [101,102]. In addition, G. glabra was shown to enhance humoral immunity through increasing B-cell activation and proliferation [103].

1.2.8. Shatavari (Asparagus racemosus)

Shatavari (Asparagus racemosus) is also a traditional herb that has been used for ages to treat several diseases due to its role as an immunomodulator [104,105]. As in many herbs, the active components responsible for the immune responses in G. frondosa are saponins, flavonoids, and polysaccharides [106]. A. racemosus has been shown to enhance the activity of various immune cells like macrophages, neutrophils, and natural killer (NK) cells, thus contributing to defense against bacterial and viral infections [107]. A. racemosus was shown to inhibit pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-α), interleukin 1β, interleukin-6 (IL-6), and nitric oxide, while upregulating Th1 and Th2 cytokines (IL-2 and IL-4), thereby balancing the cytokine-involved immune response [108,109].

1.2.9. Tulsi (Ocimum sanctum)

Tulsi (Ocimum sanctum) is very commonly used in India as an herbal plant to treat various medical conditions. It has been shown to alleviate inflammatory responses and boost the immune system in a number of ways. O. sanctum has been shown to increase the levels of IL-4, IFN-γ, and NK and T-cells [43]. It has been suggested that O. sanctum induces both bacterial and viral activities against a number of pathogens [110,111]. The active components responsible for most antimicrobial effects of Tulsi are terpenes, phenolics, phenolic acids, and flavonoids [112].
In addition to these medicinal herbs, there are several other herbs listed in (Table 2) that contribute to antimicrobial defense. The active herbal components with immunomodulatory effects are described in (Table 2).

2. Discussion

Natural compounds and molecules, derived from plants, represent an integral part of the development of therapeutic agents. The therapeutic role of bioactive compounds has been evaluated in a number of microbial diseases. It was shown that these compounds enhance the immune system in a number of ways, such as balancing pro- and anti-inflammatory cytokines (Figures S1–S10). Although there are studies showing the robust therapeutic effects of natural products, there are few clinical trials that practically test the benefits of natural products in serious diseases. One obstacle preventing the inclusion of natural products in many clinical trials is the absence of comprehensive data regarding both their safety and underlying mechanisms of action. In this review, we attempted to explore the recent therapeutic effects of natural products in a number of diseases. Certain products such as flavonoids play an immunomodulatory role in several medical conditions, suggesting their potential as candidates for treating infections.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/molecules28248045/s1, Figures S1–S10: Pro and anti-inflammatory cytokines affected by Echinacea, Astragalus, Maitake, Garlic, Shatavari, Ginseng, Ashwagandha, Licorice, Tulsi, and Ginger.

Author Contributions

Conceptualization, H.H.A.; methodology, H.H.A.; software, H.H.A.; validation, H.H.A., A.M.E., M.K.A. and E.F.E.A.; formal analysis, H.H.A.; investigation, H.H.A.; resources, H.H.A.; data curation, H.H.A.; writing—original draft preparation, H.H.A.; writing—review and editing, H.H.A., A.M.E., M.K.A. and E.F.E.A.; visualization, H.H.A., A.M.E., M.K.A. and E.F.E.A.; supervision, H.H.A.; project administration, H.H.A.; funding acquisition, H.H.A. All authors have read and agreed to the published version of the manuscript.

Funding

This work was funded by the Deanship of Graduate Studies and Scientific Research at Jouf University under grant No (DSR2023-01-02212).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

The authors acknowledge the Department of Clinical Laboratory Science, College of Applied Medical Sciences-Qurayyat, Jouf University, Al Jouf, Saudi Arabia, for supporting this work.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Mogensen, T.H. Pathogen recognition and inflammatory signaling in innate immune defenses. Clin. Microbiol. Rev. 2009, 22, 240–273. [Google Scholar] [CrossRef] [PubMed]
  2. Andres, C.M.C.; Perez de la Lastra, J.M.; Juan, C.A.; Plou, F.J.; Perez-Lebena, E. The Role of Reactive Species on Innate Immunity. Vaccines 2022, 10, 1735. [Google Scholar] [CrossRef] [PubMed]
  3. Iwasaki, A.; Medzhitov, R. Control of adaptive immunity by the innate immune system. Nat. Immunol. 2015, 16, 343–353. [Google Scholar] [CrossRef] [PubMed]
  4. Thakur, A.; Mikkelsen, H.; Jungersen, G. Intracellular Pathogens: Host Immunity and Microbial Persistence Strategies. J. Immunol. Res. 2019, 2019, 1356540. [Google Scholar] [CrossRef] [PubMed]
  5. Marshall, J.S.; Warrington, R.; Watson, W.; Kim, H.L. An introduction to immunology and immunopathology. Allergy Asthma Clin. Immunol. 2018, 14, 49. [Google Scholar] [CrossRef] [PubMed]
  6. Lipscomb, M.F.; Masten, B.J. Dendritic cells: Immune regulators in health and disease. Physiol. Rev. 2002, 82, 97–130. [Google Scholar] [CrossRef] [PubMed]
  7. Ermakov, E.A.; Nevinsky, G.A.; Buneva, V.N. Immunoglobulins with Non-Canonical Functions in Inflammatory and Autoimmune Disease States. Int. J. Mol. Sci. 2020, 21, 5392. [Google Scholar] [CrossRef] [PubMed]
  8. Pirofski, L.A.; Casadevall, A. Immunomodulators as an antimicrobial tool. Curr. Opin. Microbiol. 2006, 9, 489–495. [Google Scholar] [CrossRef]
  9. Petroni, G.; Buqué, A.; Zitvogel, L.; Kroemer, G.; Galluzzi, L. Immunomodulation by targeted anticancer agents. Cancer Cell 2021, 39, 310–345. [Google Scholar] [CrossRef]
  10. Pahar, B.; Madonna, S.; Das, A.; Albanesi, C.; Girolomoni, G. Immunomodulatory role of the antimicrobial LL-37 peptide in autoimmune diseases and viral infections. Vaccines 2020, 8, 517. [Google Scholar] [CrossRef]
  11. Fung, J.J. Tacrolimus and transplantation: A decade in review. Transplantation 2004, 77, S41–S43. [Google Scholar] [CrossRef]
  12. Cassone, G.; Manfredi, A.; Vacchi, C.; Luppi, F.; Coppi, F.; Salvarani, C.; Sebastiani, M. Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lights and Shadows. J. Clin. Med. 2020, 9, 1082. [Google Scholar] [CrossRef] [PubMed]
  13. González-Navajas, J.M.; Lee, J.; David, M.; Raz, E. Immunomodulatory functions of type I interferons. Nat. Rev. Immunol. 2012, 12, 125–135. [Google Scholar] [CrossRef] [PubMed]
  14. Bode, A.M.; Dong, Z. The amazing and mighty ginger. In Herbal Medicine: Biomolecular and Clinical Aspects, 2nd ed.; CRC Press/Taylor & Francis: Boca Raton, FL, USA, 2011. [Google Scholar]
  15. Tharakan, A.; Shukla, H.; Benny, I.R.; Tharakan, M.; George, L.; Koshy, S. Immunomodulatory Effect of Withania somnifera (Ashwagandha) Extract—A Randomized, Double-Blind, Placebo Controlled Trial with an Open Label Extension on Healthy Participants. J. Clin. Med. 2021, 10, 3644. [Google Scholar] [CrossRef] [PubMed]
  16. Sikandan, A.; Shinomiya, T.; Nagahara, Y. Ashwagandha root extract exerts anti-inflammatory effects in HaCaT cells by inhibiting the MAPK/NF-kappaB pathways and by regulating cytokines. Int. J. Mol. Med. 2018, 42, 425–434. [Google Scholar] [CrossRef] [PubMed]
  17. Denzler, K.; Moore, J.; Harrington, H.; Morrill, K.; Huynh, T.; Jacobs, B.; Waters, R.; Langland, J. Characterization of the Physiological Response following In Vivo Administration of Astragalus membranaceus. Evid. Based Complement. Altern. Med. 2016, 2016, 6861078. [Google Scholar] [CrossRef] [PubMed]
  18. Chen, X.; Chen, X.; Gao, J.; Yang, H.; Duan, Y.; Feng, Y.; He, X.; Gong, X.; Wang, H.; Wu, X.; et al. Astragaloside III Enhances Anti-Tumor Response of NK Cells by Elevating NKG2D and IFN-gamma. Front. Pharmacol. 2019, 10, 898. [Google Scholar] [CrossRef] [PubMed]
  19. Zhang, X.; Liang, T.; Yang, W.; Zhang, L.; Wu, S.; Yan, C.; Li, Q. Astragalus membranaceus Injection Suppresses Production of Interleukin-6 by Activating Autophagy through the AMPK-mTOR Pathway in Lipopolysaccharide-Stimulated Macrophages. Oxid. Med. Cell. Longev. 2020, 2020, 1364147. [Google Scholar] [CrossRef] [PubMed]
  20. Yang, C.M.; Han, Q.J.; Wang, K.L.; Xu, Y.L.; Lan, J.H.; Cao, G.T. Astragalus and Ginseng Polysaccharides Improve Developmental, Intestinal Morphological, and Immune Functional Characters of Weaned Piglets. Front. Physiol. 2019, 10, 418. [Google Scholar] [CrossRef]
  21. Catanzaro, M.; Corsini, E.; Rosini, M.; Racchi, M.; Lanni, C. Immunomodulators Inspired by Nature: A Review on Curcumin and Echinacea. Molecules 2018, 23, 2778. [Google Scholar] [CrossRef]
  22. Zhai, Z.; Liu, Y.; Wu, L.; Senchina, D.S.; Wurtele, E.S.; Murphy, P.A.; Kohut, M.L.; Cunnick, J.E. Enhancement of innate and adaptive immune functions by multiple Echinacea species. J. Med. Food 2007, 10, 423–434. [Google Scholar] [CrossRef] [PubMed]
  23. Arreola, R.; Quintero-Fabian, S.; Lopez-Roa, R.I.; Flores-Gutierrez, E.O.; Reyes-Grajeda, J.P.; Carrera-Quintanar, L.; Ortuno-Sahagun, D. Immunomodulation and anti-inflammatory effects of garlic compounds. J. Immunol. Res. 2015, 2015, 401630. [Google Scholar] [CrossRef] [PubMed]
  24. Lestari, S.R.; Atho’illah, M.F.; Christina, Y.I.; Rifa’i, M. Single garlic oil modulates T cells activation and proinflammatory cytokine in mice with high fat diet. J. Ayurveda Integr. Med. 2020, 11, 414–420. [Google Scholar] [CrossRef] [PubMed]
  25. Padiyappa, S.D.; Avalappa, H.; Somegowda, M.; Sridhara, S.; Venkatesh, Y.P.; Prabhakar, B.T.; Pramod, S.N.; Almujaydil, M.S.; Shokralla, S.; Abdelbacki, A.M.M.; et al. Immunoadjuvant and Humoral Immune Responses of Garlic (Allium sativum L.) Lectins upon Systemic and Mucosal Administration in BALB/c Mice. Molecules 2022, 27, 1375. [Google Scholar] [CrossRef] [PubMed]
  26. Washiya, Y.; Nishikawa, T.; Fujino, T. Enhancement of intestinal IgA production by Ajoene in mice. Biosci. Biotechnol. Biochem. 2013, 77, 2298–2301. [Google Scholar] [CrossRef] [PubMed]
  27. Liu, C.T.; Su, H.M.; Lii, C.K.; Sheen, L.Y. Effect of supplementation with garlic oil on activity of Th1 and Th2 lymphocytes from rats. Planta Medica 2009, 75, 205–210. [Google Scholar] [CrossRef] [PubMed]
  28. Ishikawa, H.; Saeki, T.; Otani, T.; Suzuki, T.; Shimozuma, K.; Nishino, H.; Fukuda, S.; Morimoto, K. Aged garlic extract prevents a decline of NK cell number and activity in patients with advanced cancer. J. Nutr. 2006, 136, 816S–820S. [Google Scholar] [CrossRef]
  29. Jiang, T.A. Health benefits of culinary herbs and spices. J. AOAC Int. 2019, 102, 395–411. [Google Scholar] [CrossRef]
  30. Ballester, P.; Cerdá, B.; Arcusa, R.; Marhuenda, J.; Yamedjeu, K.; Zafrilla, P. Effect of Ginger on Inflammatory Diseases. Molecules 2022, 27, 7223. [Google Scholar] [CrossRef]
  31. Aryaeian, N.; Shahram, F.; Mahmoudi, M.; Tavakoli, H.; Yousefi, B.; Arablou, T.; Karegar, S.J. The effect of ginger supplementation on some immunity and inflammation intermediate genes expression in patients with active Rheumatoid Arthritis. Gene 2019, 698, 179–185. [Google Scholar] [CrossRef]
  32. Kim, J.; Lee, H.; You, S. Dried Ginger Extract Restores the T Helper Type 1/T Helper Type 2 Balance and Antibody Production in Cyclophosphamide-Induced Immunocompromised Mice after Flu Vaccination. Nutrients 2022, 14, 1984. [Google Scholar] [CrossRef] [PubMed]
  33. Grudzien, M.; Rapak, A. Effect of Natural Compounds on NK Cell Activation. J. Immunol. Res. 2018, 2018, 4868417. [Google Scholar] [CrossRef] [PubMed]
  34. Sun, Y.; Guo, M.; Feng, Y.; Zheng, H.; Lei, P.; Ma, X.; Han, X.; Guan, H.; Hou, D. Effect of ginseng polysaccharides on NK cell cytotoxicity in immunosuppressed mice. Exp. Ther. Med. 2016, 12, 3773–3777. [Google Scholar] [CrossRef] [PubMed]
  35. Kang, S.; Min, H. Ginseng, the ‘Immunity Boost’: The Effects of Panax ginseng on Immune System. J. Ginseng Res. 2012, 36, 354–368. [Google Scholar] [CrossRef] [PubMed]
  36. Song, X.; Chen, J.; Sakwiwatkul, K.; Li, R.; Hu, S. Enhancement of immune responses to influenza vaccine (H3N2) by ginsenoside Re. Int. Immunopharmacol. 2010, 10, 351–356. [Google Scholar] [CrossRef] [PubMed]
  37. Hendricks, J.M.; Hoffman, C.; Pascual, D.W.; Hardy, M.E. 18beta-glycyrrhetinic acid delivered orally induces isolated lymphoid follicle maturation at the intestinal mucosa and attenuates rotavirus shedding. PLoS ONE 2012, 7, e49491. [Google Scholar] [CrossRef] [PubMed]
  38. Zhu, J.; Huang, R.; Yang, R.; Xiao, Y.; Yan, J.; Zheng, C.; Xiao, W.; Huang, C.; Wang, Y. Licorice extract inhibits growth of non-small cell lung cancer by down-regulating CDK4-Cyclin D1 complex and increasing CD8+ T cell infiltration. Cancer Cell Int. 2021, 21, 529. [Google Scholar] [CrossRef] [PubMed]
  39. Shi, X.; Yu, L.; Zhang, Y.; Liu, Z.; Zhang, H.; Zhang, Y.; Liu, P.; Du, P. Glycyrrhetinic acid alleviates hepatic inflammation injury in viral hepatitis disease via a HMGB1-TLR4 signaling pathway. Int. Immunopharmacol. 2020, 84, 106578. [Google Scholar] [CrossRef]
  40. Ting, Y.; Yong, T.J.; Gang, J.; Mang, L.G.; Gang, T.; Ling, C.X.; Yi, C.J.; Bo, K.; Hua, Z. Effects of dietary licorice extract on serum Biochemical index, tissues antioxidant capacity and immunity function of weaned piglets. Phytother. Res. 2020, 24, 129–135. [Google Scholar]
  41. Yu, J.-Y.; Ha, J.Y.; Kim, K.-M.; Jung, Y.-S.; Jung, J.-C.; Oh, S. Anti-inflammatory activities of licorice extract and its active compounds, glycyrrhizic acid, liquiritin and liquiritigenin, in BV2 cells and mice liver. Molecules 2015, 20, 13041–13054. [Google Scholar] [CrossRef]
  42. Bhat, J.; Damle, A.; Vaishnav, P.P.; Albers, R.; Joshi, M.; Banerjee, G. In vivo enhancement of natural killer cell activity through tea fortified with Ayurvedic herbs. Phytother. Res. Int. J. Devoted Pharmacol. Toxicol. Eval. Nat. Prod. Deriv. 2010, 24, 129–135. [Google Scholar] [CrossRef] [PubMed]
  43. Mondal, S.; Varma, S.; Bamola, V.D.; Naik, S.N.; Mirdha, B.R.; Padhi, M.M.; Mehta, N.; Mahapatra, S.C. Double-blinded randomized controlled trial for immunomodulatory effects of Tulsi (Ocimum sanctum Linn.) leaf extract on healthy volunteers. J. Ethnopharmacol. 2011, 136, 452–456. [Google Scholar] [CrossRef] [PubMed]
  44. Goel, A.; Singh, D.K.; Kumar, S.; Bhatia, A.K. Immunomodulating property of Ocimum sanctum by regulating the IL-2 production and its mRNA expression using rat’s splenocytes. Asian Pac. J. Trop. Med. 2010, 3, 8–12. [Google Scholar] [CrossRef]
  45. Mikulska, P.; Malinowska, M.; Ignacyk, M.; Szustowski, P.; Nowak, J.; Pesta, K.; Szelag, M.; Szklanny, D.; Judasz, E.; Kaczmarek, G.; et al. Ashwagandha (Withania somnifera)—Current Research on the Health-Promoting Activities: A Narrative Review. Pharmaceutics 2023, 15, 1057. [Google Scholar] [CrossRef] [PubMed]
  46. Alanazi, H.H.; Elfaki, E. The immunomodulatory role of Withania somnifera (L.) dunal in inflammatory diseases. Front. Pharmacol. 2023, 14, 1084757. [Google Scholar] [CrossRef] [PubMed]
  47. Sehgal, N.; Gupta, A.; Valli, R.K.; Joshi, S.D.; Mills, J.T.; Hamel, E.; Khanna, P.; Jain, S.C.; Thakur, S.S.; Ravindranath, V. Withania somnifera reverses Alzheimer’s disease pathology by enhancing low-density lipoprotein receptor-related protein in liver. Proc. Natl. Acad. Sci. USA 2012, 109, 3510–3515. [Google Scholar] [CrossRef] [PubMed]
  48. Dutta, R.; Khalil, R.; Green, R.; Mohapatra, S.S.; Mohapatra, S. Withania somnifera (Ashwagandha) and Withaferin A: Potential in Integrative Oncology. Int. J. Mol. Sci. 2019, 20, 5310. [Google Scholar] [CrossRef] [PubMed]
  49. Henley, A.B.; Yang, L.; Chuang, K.L.; Sahuri-Arisoylu, M.; Wu, L.H.; Bligh, S.W.; Bell, J.D. Withania somnifera Root Extract Enhances Chemotherapy through ‘Priming’. PLoS ONE 2017, 12, e0170917. [Google Scholar] [CrossRef]
  50. Udayakumar, R.; Kasthurirengan, S.; Mariashibu, T.S.; Rajesh, M.; Anbazhagan, V.R.; Kim, S.C.; Ganapathi, A.; Choi, C.W. Hypoglycaemic and hypolipidaemic effects of Withania somnifera root and leaf extracts on alloxan-induced diabetic rats. Int. J. Mol. Sci. 2009, 10, 2367–2382. [Google Scholar] [CrossRef]
  51. Khan, M.A.; Ahmed, R.S.; Chandra, N.; Arora, V.K.; Ali, A. In vivo, Extract from Withania somnifera Root Ameliorates Arthritis via Regulation of Key Immune Mediators of Inflammation in Experimental Model of Arthritis. Antiinflamm. Antiallergy Agents Med. Chem. 2019, 18, 55–70. [Google Scholar] [CrossRef]
  52. Liu, P.; Zhao, H.; Luo, Y. Anti-Aging Implications of Astragalus membranaceus (Huangqi): A Well-Known Chinese Tonic. Aging Dis. 2017, 8, 868–886. [Google Scholar] [CrossRef] [PubMed]
  53. Hou, Y.C.; Wu, J.M.; Wang, M.Y.; Wu, M.H.; Chen, K.Y.; Yeh, S.L.; Lin, M.T. Modulatory Effects of Astragalus Polysaccharides on T-Cell Polarization in Mice with Polymicrobial Sepsis. Mediat. Inflamm. 2015, 2015, 826319. [Google Scholar] [CrossRef] [PubMed]
  54. Zhang, Z.; Zhang, L.; Xu, H. Effect of Astragalus polysaccharide in treatment of diabetes mellitus: A narrative review. J. Tradit. Chin. Med. 2019, 39, 133–138. [Google Scholar] [PubMed]
  55. Sun, J.; Wei, S.; Zhang, Y.; Li, J. Protective Effects of Astragalus Polysaccharide on Sepsis-Induced Acute Kidney Injury. Anal. Cell. Pathol. 2021, 2021, 7178253. [Google Scholar] [CrossRef] [PubMed]
  56. Xu, X.; Rui, S.; Chen, C.; Zhang, G.; Li, Z.; Wang, J.; Luo, Y.; Zhu, H.; Ma, X. Protective effects of astragalus polysaccharide nanoparticles on septic cardiac dysfunction through inhibition of TLR4/NF-kappaB signaling pathway. Int. J. Biol. Macromol. 2020, 153, 977–985. [Google Scholar] [CrossRef] [PubMed]
  57. Wan, C.P.; Gao, L.X.; Hou, L.F.; Yang, X.Q.; He, P.L.; Yang, Y.F.; Tang, W.; Yue, J.M.; Li, J.; Zuo, J.P. Astragaloside II triggers T cell activation through regulation of CD45 protein tyrosine phosphatase activity. Acta Pharmacol. Sin. 2013, 34, 522–530. [Google Scholar] [CrossRef] [PubMed]
  58. Yin, X.; Zhang, X.; Zhu, R.; Song, P. Effect of astragaloside IV on the immunoregulatory function of adipose-derived mesenchymal stem cells from patients with psoriasis vulgaris. J. Tradit. Chin. Med. 2022, 42, 513–519. [Google Scholar] [CrossRef]
  59. Li, Y.; Zheng, J.; Wang, Y.; Yang, H.; Cao, L.; Gan, S.; Ma, J.; Liu, H. Immuno-stimulatory activity of Astragalus polysaccharides in cyclophosphamide-induced immunosuppressed mice by regulating gut microbiota. Int. J. Biol. Macromol. 2023, 242, 124789. [Google Scholar] [CrossRef]
  60. Wei, D.; Xu, H.; Gai, X.; Jiang, Y. Astragaloside IV alleviates myocardial ischemia-reperfusion injury in rats through regulating PI3K/AKT/GSK-3beta signaling pathways. Acta Cir. Bras. 2019, 34, e201900708. [Google Scholar] [CrossRef]
  61. Kim, J.; Moon, E.; Kwon, S. Effect of Astragalus membranaceus extract on diabetic nephropathy. Endocrinol. Diabetes Metab. Case Rep. 2014, 2014, 140063. [Google Scholar] [CrossRef]
  62. Goto, S.; Fujii, H.; Watanabe, K.; Shimizu, M.; Okamoto, H.; Sakamoto, K.; Kono, K.; Nishi, S. Renal protective effects of astragalus root in rat models of chronic kidney disease. Clin. Exp. Nephrol. 2023, 27, 593–602. [Google Scholar] [CrossRef] [PubMed]
  63. Zhou, R.; Chen, H.; Chen, J.; Chen, X.; Wen, Y.; Xu, L. Extract from Astragalus membranaceus inhibit breast cancer cells proliferation via PI3K/AKT/mTOR signaling pathway. BMC Complement. Altern. Med. 2018, 18, 83. [Google Scholar] [CrossRef] [PubMed]
  64. Chang, H.L.; Kuo, Y.H.; Wu, L.H.; Chang, C.M.; Cheng, K.J.; Tyan, Y.C.; Lee, C.H. The extracts of Astragalus membranaceus overcome tumor immune tolerance by inhibition of tumor programmed cell death protein ligand-1 expression. Int. J. Med. Sci. 2020, 17, 939–945. [Google Scholar] [CrossRef] [PubMed]
  65. Manayi, A.; Vazirian, M.; Saeidnia, S. Echinacea purpurea: Pharmacology, phytochemistry and analysis methods. Pharmacogn. Rev. 2015, 9, 63–72. [Google Scholar] [CrossRef]
  66. Abbas, A.; Iqbal, Z.; Abbas, R.Z.; Khan, M.K.; Khan, J.A. Immunomodulatory activity of Pinus radiata extract against coccidiosis in broiler chicken. Pak. Vet. J. 2017, 37, 145–149. [Google Scholar]
  67. Park, S.J.; Lee, M.; Kim, D.; Oh, D.H.; Prasad, K.S.; Eun, S.; Lee, J. Echinacea purpurea Extract Enhances Natural Killer Cell Activity In Vivo by Upregulating MHC II and Th1-type CD4(+) T Cell Responses. J. Med. Food 2021, 24, 1039–1049. [Google Scholar] [CrossRef] [PubMed]
  68. Vieira, S.F.; Goncalves, S.M.; Goncalves, V.M.F.; Llaguno, C.P.; Macias, F.; Tiritan, M.E.; Cunha, C.; Carvalho, A.; Reis, R.L.; Ferreira, H.; et al. Echinacea purpurea Fractions Represent Promising Plant-Based Anti-Inflammatory Formulations. Antioxidants 2023, 12, 425. [Google Scholar] [CrossRef] [PubMed]
  69. Raso, G.M.; Pacilio, M.; Di Carlo, G.; Esposito, E.; Pinto, L.; Meli, R. In-vivo and in-vitro anti-inflammatory effect of Echinacea purpurea and Hypericum perforatum. J. Pharm. Pharmacol. 2002, 54, 1379–1383. [Google Scholar] [CrossRef]
  70. Ciganovic, P.; Jakupovic, L.; Momchev, P.; Nizic Nodilo, L.; Hafner, A.; Zovko Koncic, M. Extraction Optimization, Antioxidant, Cosmeceutical and Wound Healing Potential of Echinacea purpurea Glycerolic Extracts. Molecules 2023, 28, 1177. [Google Scholar] [CrossRef]
  71. Mao, C.F.; Sudirman, S.; Lee, C.C.; Tsou, D.; Kong, Z.L. Echinacea purpurea Ethanol Extract Improves Male Reproductive Dysfunction with Streptozotocin-Nicotinamide-Induced Diabetic Rats. Front. Vet. Sci. 2021, 8, 651286. [Google Scholar] [CrossRef]
  72. Bayan, L.; Koulivand, P.H.; Gorji, A. Garlic: A review of potential therapeutic effects. Avicenna J. Phytomed. 2014, 4, 1–14. [Google Scholar] [PubMed]
  73. Ried, K. Garlic lowers blood pressure in hypertensive subjects, improves arterial stiffness and gut microbiota: A review and meta-analysis. Exp. Ther. Med. 2020, 19, 1472–1478. [Google Scholar] [CrossRef] [PubMed]
  74. Rouf, R.; Uddin, S.J.; Sarker, D.K.; Islam, M.T.; Ali, E.S.; Shilpi, J.A.; Nahar, L.; Tiralongo, E.; Sarker, S.D. Antiviral potential of garlic (Allium sativum) and its organosulfur compounds: A systematic update of pre-clinical and clinical data. Trends Food Sci. Technol. 2020, 104, 219–234. [Google Scholar] [CrossRef] [PubMed]
  75. Padiya, R.; Khatua, T.N.; Bagul, P.K.; Kuncha, M.; Banerjee, S.K. Garlic improves insulin sensitivity and associated metabolic syndromes in fructose fed rats. Nutr. Metab. 2011, 8, 53. [Google Scholar] [CrossRef] [PubMed]
  76. Kshirsagar, M.M.; Dodamani, A.S.; Karibasappa, G.N.; Vishwakarma, P.K.; Vathar, J.B.; Sonawane, K.R.; Jadhav, H.C.; Khobragade, V.R. Antibacterial activity of garlic extract on cariogenic bacteria: An in vitro study. Ayu 2018, 39, 165–168. [Google Scholar] [CrossRef] [PubMed]
  77. Banerjee, M.; Sarkar, P.K. Inhibitory effect of garlic on bacterial pathogens from spices. World J. Microbiol. Biotechnol. 2003, 19, 565–569. [Google Scholar] [CrossRef]
  78. Zhang, Y.; Liu, X.; Ruan, J.; Zhuang, X.; Zhang, X.; Li, Z. Phytochemicals of garlic: Promising candidates for cancer therapy. Biomed. Pharmacother. 2020, 123, 109730. [Google Scholar] [CrossRef]
  79. Pandey, P.; Khan, F.; Alshammari, N.; Saeed, A.; Aqil, F.; Saeed, M. Updates on the anticancer potential of garlic organosulfur compounds and their nanoformulations: Plant therapeutics in cancer management. Front. Pharmacol. 2023, 14, 1154034. [Google Scholar] [CrossRef]
  80. Butt, M.S.; Sultan, M.T. Ginger and its health claims: Molecular aspects. Crit. Rev. Food Sci. Nutr. 2011, 51, 383–393. [Google Scholar] [CrossRef]
  81. Zhang, M.; Viennois, E.; Prasad, M.; Zhang, Y.; Wang, L.; Zhang, Z.; Han, M.K.; Xiao, B.; Xu, C.; Srinivasan, S.; et al. Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer. Biomaterials 2016, 101, 321–340. [Google Scholar] [CrossRef]
  82. Ahmed, N.; Karobari, M.I.; Yousaf, A.; Mohamed, R.N.; Arshad, S.; Basheer, S.N.; Peeran, S.W.; Noorani, T.Y.; Assiry, A.A.; Alharbi, A.S.; et al. The antimicrobial efficacy against selective oral microbes, antioxidant activity and preliminary phytochemical screening of Zingiber officinale. Infect. Drug Resist. 2022, 15, 2773–2785. [Google Scholar] [CrossRef] [PubMed]
  83. Ike, K.; Uchida, Y.; Nakamura, T.; Imai, S. Induction of interferon-gamma (IFN-γ) and T helper 1 (Th1) immune response by bitter gourd extract. J. Vet. Med. Sci. 2005, 67, 521–524. [Google Scholar] [CrossRef] [PubMed]
  84. Qorbanpour, M.; Fahim, T.; Javandel, F.; Nosrati, M.; Paz, E.; Seidavi, A.; Ragni, M.; Laudadio, V.; Tufarelli, V. Effect of dietary ginger (Zingiber officinale Roscoe) and multi-strain probiotic on growth and carcass traits, blood biochemistry, immune responses and intestinal microflora in broiler chickens. Animals 2018, 8, 117. [Google Scholar] [CrossRef] [PubMed]
  85. Aryaeian, N.; Mahmoudi, M.; Shahram, F.; Poursani, S.; Jamshidi, F.; Tavakoli, H. The effect of ginger supplementation on IL2, TNFalpha, and IL1beta cytokines gene expression levels in patients with active rheumatoid arthritis: A randomized controlled trial. Med. J. Islam. Repub. Iran 2019, 33, 154. [Google Scholar] [PubMed]
  86. Khandouzi, N.; Shidfar, F.; Rajab, A.; Rahideh, T.; Hosseini, P.; Mir Taheri, M. The effects of ginger on fasting blood sugar, hemoglobin a1c, apolipoprotein B, apolipoprotein a-I and malondialdehyde in type 2 diabetic patients. Iran. J. Pharm. Res. 2015, 14, 131–140. [Google Scholar] [PubMed]
  87. Prasad, S.; Tyagi, A.K. Ginger and its constituents: Role in prevention and treatment of gastrointestinal cancer. Gastroenterol. Res. Pract. 2015, 2015, 142979. [Google Scholar] [CrossRef] [PubMed]
  88. Liu, H.; Lu, X.; Hu, Y.; Fan, X. Chemical constituents of Panax ginseng and Panax notoginseng explain why they differ in therapeutic efficacy. Pharmacol. Res. 2020, 161, 105263. [Google Scholar] [CrossRef] [PubMed]
  89. Park, T.Y.; Hong, M.; Sung, H.; Kim, S.; Suk, K.T. Effect of Korean Red Ginseng in chronic liver disease. J. Ginseng Res. 2017, 41, 450–455. [Google Scholar] [CrossRef]
  90. Yan, M.; Diao, M.; Zhang, C.; Shen, X.; Zhan, X.; Xi, C.; Zhao, C.; Zhang, T. Lactoferrin-ginsenoside Rg3 complex ingredients: Study of interaction mechanism and preparation of oil-in-water emulsion. Food Chem. 2021, 363, 130239. [Google Scholar] [CrossRef]
  91. Nakaya, T.-A.; Kita, M.; Kuriyama, H.; Iwakura, Y.; Imanishi, J. Panax ginseng induces production of proinflammatory cytokines via toll-like receptor. J. Interferon Cytokine Res. 2004, 24, 93–100. [Google Scholar] [CrossRef]
  92. Nguyen, N.H.; Nguyen, C.T. Pharmacological effects of ginseng on infectious diseases. Inflammopharmacology 2019, 27, 871–883. [Google Scholar] [CrossRef] [PubMed]
  93. Kim, H.-J.; Kim, M.-H.; Byon, Y.-Y.; Park, J.W.; Jee, Y.; Joo, H.-G. Radioprotective effects of an acidic polysaccharide of Panax ginseng on bone marrow cells. J. Vet. Sci. 2007, 8, 39–44. [Google Scholar] [CrossRef] [PubMed]
  94. Cho, J.Y.; Kim, A.R.; Yoo, E.S.; Baik, K.U.; Park, M.H. Ginsenosides from Panax ginseng differentially regulate lymphocyte proliferation. Planta Medica 2002, 68, 497–500. [Google Scholar] [CrossRef] [PubMed]
  95. Tanaka, Y.; Kikuzaki, H.; Fukuda, S.; Nakatani, N. Antibacterial compounds of licorice against upper airway respiratory tract pathogens. J. Nutr. Sci. Vitaminol. 2001, 47, 270–273. [Google Scholar] [CrossRef] [PubMed]
  96. Yang, R.; Yuan, B.-C.; Ma, Y.-S.; Zhou, S.; Liu, Y. The anti-inflammatory activity of licorice, a widely used Chinese herb. Pharm. Biol. 2017, 55, 5–18. [Google Scholar] [CrossRef] [PubMed]
  97. Saeedi, M.; Morteza-Semnani, K.; Ghoreishi, M.R. The treatment of atopic dermatitis with licorice gel. J. Dermatol. Treat. 2003, 14, 153–157. [Google Scholar] [CrossRef] [PubMed]
  98. Yang, R.; Wang, L.-Q.; Yuan, B.-C.; Liu, Y. The pharmacological activities of licorice. Planta Medica 2015, 81, 1654–1669. [Google Scholar] [CrossRef]
  99. Wei, J.-H.; Zheng, Y.-F.; Li, C.-Y.; Tang, Y.-P.; Peng, G.-P. Bioactive constituents of oleanane-type triterpene saponins from the roots of Glycyrrhiza glabra. J. Asian Nat. Prod. Res. 2014, 16, 1044–1053. [Google Scholar] [CrossRef]
  100. Alagawany, M.; Elnesr, S.S.; Farag, M.R.; Abd El-Hack, M.E.; Khafaga, A.F.; Taha, A.E.; Tiwari, R.; Yatoo, M.I.; Bhatt, P.; Marappan, G.; et al. Use of licorice (Glycyrrhiza glabra) herb as a feed additive in poultry: Current knowledge and prospects. Animals 2019, 9, 536. [Google Scholar] [CrossRef]
  101. Guo, A.; He, D.; Xu, H.-B.; Geng, C.-A.; Zhao, J. Promotion of regulatory T cell induction by immunomodulatory herbal medicine licorice and its two constituents. Sci. Rep. 2015, 5, 14046. [Google Scholar] [CrossRef]
  102. Bordbar, N.; Karimi, M.H.; Amirghofran, Z. The effect of glycyrrhizin on maturation and T cell stimulating activity of dendritic cells. Cell. Immunol. 2012, 280, 44–49. [Google Scholar] [CrossRef] [PubMed]
  103. Dorhoi, A.; Dobrean, V.; Zăhan, M.; Virag, P. Modulatory effects of several herbal extracts on avian peripheral blood cell immune responses. Phytother. Res. Int. J. Devoted Pharmacol. Toxicol. Eval. Nat. Prod. Deriv. 2006, 20, 352–358. [Google Scholar] [CrossRef] [PubMed]
  104. Veena, N.; Arora, S.; Kapila, S.; Singh, R.R.B.; Katara, A.; Pandey, M.M.; Rastogi, S.; Rawat, A.K.S. Immunomodulatory and antioxidative potential of milk fortified with Asparagus racemosus (Shatavari). J. Mech. Phys. Solids 2014, 2, 13–19. [Google Scholar]
  105. Gautam, M.; Saha, S.; Bani, S.; Kaul, A.; Mishra, S.; Patil, D.; Satti, N.; Suri, K.; Gairola, S.; Suresh, K. Immunomodulatory activity of Asparagus racemosus on systemic Th1/Th2 immunity: Implications for immunoadjuvant potential. J. Ethnopharmacol. 2009, 121, 241–247. [Google Scholar] [CrossRef] [PubMed]
  106. Mishra, J.N.; Verma, N.K. Asparagus racemosus: Chemical constituents and pharmacological activities—A review. Eur. J. Biomed. Pharm. Sci. 2017, 4, 207–213. [Google Scholar]
  107. Shaha, P.; Bellankimath, A. Pharmacological profile of Asparagus racemosus: A review. Int. J. Curr. Microbiol. Appl. Sci. 2017, 6, 1215–1223. [Google Scholar] [CrossRef]
  108. Kanwar, A.S.; Bhutani, K.K. Effects of Chlorophytum arundinaceum, Asparagus adscendens and Asparagus racemosus on pro-inflammatory cytokine and corticosterone levels produced by stress. Phytother. Res. 2010, 24, 1562–1566. [Google Scholar] [CrossRef] [PubMed]
  109. Singh, N.; Garg, M.; Prajapati, P.; Singh, P.K.; Chopra, R.; Kumari, A.; Mittal, A. Adaptogenic property of Asparagus racemosus: Future trends and prospects. Heliyon 2023, 9, e14932. [Google Scholar] [CrossRef]
  110. Yamani, H.A.; Pang, E.C.; Mantri, N.; Deighton, M.A. Antimicrobial Activity of Tulsi (Ocimum tenuiflorum) Essential Oil and Their Major Constituents against Three Species of Bacteria. Front. Microbiol. 2016, 7, 681. [Google Scholar] [CrossRef]
  111. Cohen, M.M. Tulsi—Ocimum sanctum: A herb for all reasons. J. Ayurveda Integr. Med. 2014, 5, 251–259. [Google Scholar] [CrossRef]
  112. Chaudhary, A.; Sharma, S.; Mittal, A.; Gupta, S.; Dua, A. Phytochemical and antioxidant profiling of Ocimum sanctum. J. Food Sci. Technol. 2020, 57, 3852–3863. [Google Scholar] [CrossRef] [PubMed]
  113. Gaurav, H.; Yadav, D.; Maurya, A.; Yadav, H.; Yadav, R.; Shukla, A.C.; Sharma, M.; Gupta, V.K.; Palazon, J. Biodiversity, Biochemical Profiling, and Pharmaco-Commercial Applications of Withania somnifera: A Review. Molecules 2023, 28, 1208. [Google Scholar] [CrossRef] [PubMed]
  114. Munir, N.; Mahmood, Z.; Shahid, M.; Afzal, M.N.; Jahangir, M.; Ali Shah, S.M.; Tahir, I.M.; Riaz, M.; Hussain, S.; Akram, M.; et al. Withania somnifera Chemical Constituents’ In Vitro Antioxidant Potential and Their Response on Spermatozoa Parameters. Dose Response 2022, 20, 15593258221074936. [Google Scholar] [CrossRef] [PubMed]
  115. Zheng, Y.; Ren, W.; Zhang, L.; Zhang, Y.; Liu, D.; Liu, Y. A Review of the Pharmacological Action of Astragalus Polysaccharide. Front. Pharmacol. 2020, 11, 349. [Google Scholar] [CrossRef] [PubMed]
  116. Fu, J.; Wang, Z.; Huang, L.; Zheng, S.; Wang, D.; Chen, S.; Zhang, H.; Yang, S. Review of the botanical characteristics, phytochemistry, and pharmacology of Astragalus membranaceus (Huangqi). Phytother. Res. 2014, 28, 1275–1283. [Google Scholar] [CrossRef] [PubMed]
  117. Oniszczuk, T.; Oniszczuk, A.; Gondek, E.; Guz, L.; Puk, K.; Kocira, A.; Kusz, A.; Kasprzak, K.; Wójtowicz, A. Active polyphenolic compounds, nutrient contents and antioxidant capacity of extruded fish feed containing purple coneflower (Echinacea purpurea (L.) Moench.). Saudi J. Biol. Sci. 2019, 26, 24–30. [Google Scholar] [CrossRef] [PubMed]
  118. Shang, A.; Cao, S.Y.; Xu, X.Y.; Gan, R.Y.; Tang, G.Y.; Corke, H.; Mavumengwana, V.; Li, H.B. Bioactive Compounds and Biological Functions of Garlic (Allium sativum L.). Foods 2019, 8, 246. [Google Scholar] [CrossRef]
  119. Mao, Q.Q.; Xu, X.Y.; Cao, S.Y.; Gan, R.Y.; Corke, H.; Beta, T.; Li, H.B. Bioactive Compounds and Bioactivities of Ginger (Zingiber officinale Roscoe). Foods 2019, 8, 185. [Google Scholar] [CrossRef]
  120. Ratan, Z.A.; Haidere, M.F.; Hong, Y.H.; Park, S.H.; Lee, J.-O.; Lee, J.; Cho, J.Y. Pharmacological potential of ginseng and its major component ginsenosides. J. Ginseng Res. 2021, 45, 199–210. [Google Scholar] [CrossRef]
  121. Murray, M.T. Glycyrrhiza glabra (Licorice). In Textbook of Natural Medicine; Elsevier: Amsterdam, The Netherlands, 2020; pp. 641–647.e3. [Google Scholar]
  122. Parihar, S.; Sharma, D. A brief overview on Asparagus racemous. IJRAR 2021, 8, 96–108. [Google Scholar]
  123. Kaushal, S. Ocimum sanctum (Holy Basil)—A Herb for All Reasons; CORVETTE Press: Chittorgarh, India, 2022; p. 31. [Google Scholar]
  124. Chumroenphat, T.; Somboonwatthanakul, I.; Saensouk, S.; Siriamornpun, S. Changes in curcuminoids and chemical components of turmeric (Curcuma longa L.) under freeze-drying and low-temperature drying methods. Food Chem. 2021, 339, 128121. [Google Scholar] [CrossRef] [PubMed]
  125. Intharuksa, A.; Arunotayanun, W.; Yooin, W.; Sirisa-Ard, P. A Comprehensive Review of Andrographis paniculata (Burm. f.) Nees and Its Constituents as Potential Lead Compounds for COVID-19 Drug Discovery. Molecules 2022, 27, 4479. [Google Scholar] [CrossRef] [PubMed]
  126. Mlynarczyk, K.; Walkowiak-Tomczak, D.; Lysiak, G.P. Bioactive properties of Sambucus nigra L. as a functional ingredient for food and pharmaceutical industry. J. Funct. Foods 2018, 40, 377–390. [Google Scholar] [CrossRef] [PubMed]
  127. Yepes-Perez, A.F.; Herrera-Calderon, O.; Quintero-Saumeth, J. Uncaria tomentosa (cat’s claw): A promising herbal medicine against SARS-CoV-2/ACE-2 junction and SARS-CoV-2 spike protein based on molecular modeling. J. Biomol. Struct. Dyn. 2022, 40, 2227–2243. [Google Scholar] [CrossRef] [PubMed]
  128. Devi, P. A review on Tinospora cordifolia: As an Immunomodulating agent. Himal. J. Health Sci. 2021, 6, 6–14. [Google Scholar] [CrossRef]
  129. Thokchom, S.D.; Gupta, S.; Kapoor, R. Arbuscular mycorrhiza augments essential oil composition and antioxidant properties of Ocimum tenuiflorum L.—A popular green tea additive. Ind. Crops Prod. 2020, 153, 112418. [Google Scholar] [CrossRef]
  130. Valková, V.; Ďúranová, H.; Bilčíková, J.; Habán, M. Milk thistle (Silybum marianum): A valuable medicinal plant with several therapeutic purposes. J. Microbiol. Biotechnol. Food Sci. 2021, 2021, 836–843. [Google Scholar] [CrossRef]
  131. Kopustinskiene, D.M.; Bernatoniene, J. Antioxidant effects of Schisandra chinensis fruits and their active constituents. Antioxidants 2021, 10, 620. [Google Scholar] [CrossRef]
  132. Mullaicharam, A.; Halligudi, N. St John’s wort (Hypericum perforatum L.): A Review of its Chemistry, Pharmacology and Clinical properties. Int. J. Res. Phytochem. Pharmacol. Sci. 2019, 1, 5–11. [Google Scholar] [CrossRef]
  133. Gahatraj, S.; Bhusal, B.; Sapkota, K.; Dhami, B.; Gautam, D. Common medicinal plants of Nepal: A review of Triphala: Harro (Terminalia chebula), Barro (Terminalia bellirica), and Amala (Emblica officinalis). Asian J. Pharmacogn. 2020, 4, 5–13. [Google Scholar]
  134. Kaviya, M.; Balamuralikrishnan, B.; Sangeetha, T.; Senthilkumar, N.; Malaisamy, A.; Sivasamy, M.; Poorni, L.; Pushparaj, K.; Arun, M.; Anand, A.V. Evaluation of phytoconstituents of Triticum aestivum grass extracts on nutritional attributes, antioxidant, and antimicrobial activities against food pathogens with molecular in silico investigation. Food Front. 2023, 4, 831–848. [Google Scholar] [CrossRef]
  135. Batiha, G.E.-S.; Wasef, L.; Teibo, J.O.; Shaheen, H.M.; Zakariya, A.M.; Akinfe, O.A.; Teibo, T.K.A.; Al-Kuraishy, H.M.; Al-Garbee, A.I.; Alexiou, A. Commiphora myrrh: A phytochemical and pharmacological update. Naunyn-Schmiedeberg’s Arch. Pharmacol. 2023, 396, 405–420. [Google Scholar] [CrossRef]
  136. El Mihyaoui, A.; Esteves da Silva, J.C.G.; Charfi, S.; Candela Castillo, M.E.; Lamarti, A.; Arnao, M.B. Chamomile (Matricaria chamomilla L.): A Review of Ethnomedicinal Use, Phytochemistry and Pharmacological Uses. Life 2022, 12, 479. [Google Scholar] [CrossRef] [PubMed]
  137. Le, V.; Sukhikh, A.; Larichev, T.; Ivanova, S.; Prosekov, A.; Dmitrieva, A. Isolation of the Main Biologically Active Substances and Phytochemical Analysis of Ginkgo biloba Callus Culture Extracts. Molecules 2023, 28, 1560. [Google Scholar] [CrossRef]
  138. Al-Attraqchi, O.H.; Deb, P.K.; Al-Attraqchi, N.H.A. Review of the Phytochemistry and Pharmacological Properties of Valeriana officinalis. Curr. Tradit. Med. 2020, 6, 260–277. [Google Scholar] [CrossRef]
  139. Soleimani, M.; Arzani, A.; Arzani, V.; Roberts, T.H. Phenolic compounds and antimicrobial properties of mint and thyme. J. Herb. Med. 2022, 36, 100604. [Google Scholar] [CrossRef]
  140. Kwon, Y. Use of saw palmetto (Serenoa repens) extract for benign prostatic hyperplasia. Food Sci. Biotechnol. 2019, 28, 1599–1606. [Google Scholar] [CrossRef]
  141. Ghorbani, A.; Esmaeilizadeh, M. Pharmacological properties of Salvia officinalis and its components. J. Tradit. Complement. Med. 2017, 7, 433–440. [Google Scholar] [CrossRef]
  142. Sánchez, M.; González-Burgos, E.; Iglesias, I.; Gómez-Serranillos, M.P. Pharmacological update properties of Aloe vera and its major active constituents. Molecules 2020, 25, 1324. [Google Scholar] [CrossRef]
  143. Sharma, A.; Lee, H.-J. Anti-Inflammatory Activity of Bilberry (Vaccinium myrtillus L.). Curr. Issues Mol. Biol. 2022, 44, 4570–4583. [Google Scholar] [CrossRef]
  144. Mohapatra, S.; Iqubal, A.; Ansari, M.J.; Jan, B.; Zahiruddin, S.; Mirza, M.A.; Ahmad, S.; Iqbal, Z. Benefits of black cohosh (Cimicifuga racemosa) for women health: An up-close and in-depth review. Pharmaceuticals 2022, 15, 278. [Google Scholar] [CrossRef]
  145. Pareek, A.; Suthar, M.; Rathore, G.S.; Bansal, V. Feverfew (Tanacetum parthenium L.): A systematic review. Pharmacogn. Rev. 2011, 5, 103–110. [Google Scholar] [CrossRef] [PubMed]
  146. Kumar, V.; Singh, S.; Singh, R. Phytochemical constituents of guggul and their biological qualities. Mini-Rev. Org. Chem. 2020, 17, 277–288. [Google Scholar] [CrossRef]
  147. Nazhand, A.; Lucarini, M.; Durazzo, A.; Zaccardelli, M.; Cristarella, S.; Souto, S.B.; Silva, A.M.; Severino, P.; Souto, E.B.; Santini, A. Hawthorn (Crataegus spp.): An updated overview on its beneficial properties. Forests 2020, 11, 564. [Google Scholar] [CrossRef]
  148. Marovska, G.I.; Hambarliyska, I.P.; Petkova, N.T.; Ivanov, I.G.; Vasileva, I.N.; Slavov, A.M. Chemical Composition and Antioxidant Activity of Ethanol Extracts Obtained from Lavender (Lavandula angustifolia Mill.). Philipp. J. Sci. 2023, 152, 861–870. [Google Scholar] [CrossRef]
  149. Petrisor, G.; Motelica, L.; Craciun, L.N.; Oprea, O.C.; Ficai, D.; Ficai, A. Melissa officinalis: Composition, Pharmacological Effects and Derived Release Systems—A Review. Int. J. Mol. Sci. 2022, 23, 3591. [Google Scholar] [CrossRef] [PubMed]
  150. Devkota, H.P.; Paudel, K.R.; Khanal, S.; Baral, A.; Panth, N.; Adhikari-Devkota, A.; Jha, N.K.; Das, N.; Singh, S.K.; Chellappan, D.K.; et al. Stinging Nettle (Urtica dioica L.): Nutritional Composition, Bioactive Compounds, and Food Functional Properties. Molecules 2022, 27, 5219. [Google Scholar] [CrossRef] [PubMed]
  151. Janda, K.; Wojtkowska, K.; Jakubczyk, K.; Antoniewicz, J.; Skonieczna-Zydecka, K. Passiflora incarnata in Neuropsychiatric Disorders—A Systematic Review. Nutrients 2020, 12, 3894. [Google Scholar] [CrossRef]
  152. Zhang, S.; Jiang, S.; Deng, N.; Zheng, B.; Li, T.; Liu, R.H. Phytochemical Profiles, Antioxidant Activity and Antiproliferative Mechanism of Rhodiola rosea L. Phenolic Extract. Nutrients 2022, 14, 3602. [Google Scholar] [CrossRef]
  153. Edwards, S.E.; da Costa Rocha, I.; Williamson, E.M.; Heinrich, M. Slippery Elm. In Phytopharmacy: An Evidence-Based Guide to Herbal Medicinal Products; John Wiley & Son: Hoboken, NJ, USA, 2015; p. 360. [Google Scholar]
  154. Strzępek-Gomółka, M.; Gaweł-Bęben, K.; Kukula-Koch, W. Achillea species as sources of active phytochemicals for dermatological and cosmetic applications. Oxid. Med. Cell. Longev. 2021, 2021, 6643827. [Google Scholar] [CrossRef]
  155. Wang, Z.-L.; Wang, S.; Kuang, Y.; Hu, Z.-M.; Qiao, X.; Ye, M. A comprehensive review on phytochemistry, pharmacology, and flavonoid biosynthesis of Scutellaria baicalensis. Pharm. Biol. 2018, 56, 465–484. [Google Scholar] [CrossRef] [PubMed]
  156. Shahane, K.; Kshirsagar, M.; Tambe, S.; Jain, D.; Rout, S.; Ferreira, M.K.M.; Mali, S.; Amin, P.; Srivastav, P.P.; Cruz, J.; et al. An Updated Review on the Multifaceted Therapeutic Potential of Calendula officinalis L. Pharmaceuticals 2023, 16, 611. [Google Scholar] [CrossRef] [PubMed]
  157. Kania-Dobrowolska, M.; Baraniak, J. Dandelion (Taraxacum officinale L.) as a Source of Biologically Active Compounds Supporting the Therapy of Co-Existing Diseases in Metabolic Syndrome. Foods 2022, 11, 2858. [Google Scholar] [CrossRef] [PubMed]
  158. Todorova, V.; Ivanov, K.; Ivanova, S. Comparison between the Biological Active Compounds in Plants with Adaptogenic Properties (Rhaponticum carthamoides, Lepidium meyenii, Eleutherococcus senticosus and Panax ginseng). Plants 2021, 11, 64. [Google Scholar] [CrossRef] [PubMed]
  159. Bian, T.; Corral, P.; Wang, Y.; Botello, J.; Kingston, R.; Daniels, T.; Salloum, R.G.; Johnston, E.; Huo, Z.; Lu, J.; et al. Kava as a Clinical Nutrient: Promises and Challenges. Nutrients 2020, 12, 3044. [Google Scholar] [CrossRef] [PubMed]
  160. Shah, S.; Akhtar, N.; Akram, M.; Shah, P.A.; Saeed, T.; Ahmed, K.; Asif, H. Pharmacological activity of Althaea officinalis L. J. Med. Plants Res. 2011, 5, 5662–5666. [Google Scholar]
  161. Kazlauskaite, J.A.; Ivanauskas, L.; Marksa, M.; Bernatoniene, J. The Effect of Traditional and Cyclodextrin-Assisted Extraction Methods on Trifolium pratense L. (Red Clover) Extracts Antioxidant Potential. Antioxidants 2022, 11, 435. [Google Scholar] [CrossRef] [PubMed]
  162. Marti, G.; Joulia, P.; Amiel, A.; Fabre, B.; David, B.; Fabre, N.; Fiorini-Puybaret, C. Comparison of the Phytochemical Composition of Serenoa repens Extracts by a Multiplexed Metabolomic Approach. Molecules 2019, 24, 2208. [Google Scholar] [CrossRef]
  163. Li, Y.; Ji, S.; Xu, T.; Zhong, Y.; Xu, M.; Liu, Y.; Li, M.; Fan, B.; Wang, F.; Xiao, J.; et al. Chinese yam (Dioscorea): Nutritional value, beneficial effects, and food and pharmaceutical applications. Trends Food Sci. Technol. 2023, 134, 29–40. [Google Scholar] [CrossRef]
Molecules 28 08045 g001
Figure 1. Immune components are affected by medicinal herbs. Medicinal herbs modulate the immune system in a number of ways like suppressing inflammatory cytokines and increasing anti-inflammatory cytokines or certain classes of antibodies.
Figure 1. Immune components are affected by medicinal herbs. Medicinal herbs modulate the immune system in a number of ways like suppressing inflammatory cytokines and increasing anti-inflammatory cytokines or certain classes of antibodies.
Molecules 28 08045 g001
Table 1. Overview of different immune responses induced by medicinal herbs.
Table 1. Overview of different immune responses induced by medicinal herbs.
Immunomodulatory Effects
Medicinal HerbsBioactive ComponentT-CellsB-CellsNK CellsAntibodiesPro-Inflammatory CytokinesAnti-Inflammatory CytokinesReferences
Molecules 28 08045 i001 Ashwagandha (Withania somnifera)withanolides+ + + IgA, IgM, IgG, IgG2, IgG3 and IgG4 -+[15,16]
Molecules 28 08045 i002 Astragalus (Astragalus membranaceus)polysaccharides, saponins, flavonoids, astragalosides, lipopolysaccharides+++IgG, IgA, IgM-+[17,18,19,20]
Molecules 28 08045 i003 Echinacea (Echinacea purpurea)alkamides, phenolic compounds++++-+[21,22]
Molecules 28 08045 i004 Garlic (Allium sativum)allicin, diallyl sulfide (DAS), Z-ajoene+++IgG, IgA-+[23,24,25,26,27,28]
Molecules 28 08045 i005 Ginger (Zingiber officinale)gingerol, polyphenols, shogaols, paradols, zingerone+++Total IgG, IgG1-+[29,30,31,32,33]
Molecules 28 08045 i006 Ginseng (Panax ginseng)ginsenosides, polysaccharides+++IgM, IgG1, IgG2a, IgG2b-+[34,35,36]
Molecules 28 08045 i007 Licorice (Glycyrrhiza glabra)triterpenoids, saponin, flavonoids, sterols+++IgG, IgM-+[37,38,39,40,41]
Molecules 28 08045 i008 Tulsi (Ocimum sanctum)saponins, flavonoids, terpenoids, linoleic acid+-++++[42,43,44]
(+) indicates an increase in the specified immunomodulatory component, (-) indicates a decrease in the specified immunomodulatory component.
Table 2. List of herbal active components responsible for induction of immune responses.
Table 2. List of herbal active components responsible for induction of immune responses.
Medicinal PlantsActive ComponentsReferences
1. Ashwagandha (Withania somnifera)Alkaloids, flavonoids, steroids, tannins, withanolides, and glycosides[46,113,114]
2. Astragalus (Astragalus membranaceus)Astragalus polysaccharide (APS), alkaloids, saponins, and flavonoids[115,116]
3. Echinacea (Echinacea purpurea)Alkamides, polysaccharides, caffeic acid derivatives, and cichoric acid[65,117]
4. Garlic (Allium sativum)Allicin, diallyl sulfide (DAS), diallyl disulfide (DADS), diallyl trisulfide (DATS), alliin, S-allyl-cysteine, and Z-ajoene[118]
5. Ginger (Zingiber officinale)polyphenols (Gingerols), shogaols, terpenes, polysaccharides, organic acids, and paradols[119]
6. Ginseng (Panax ginseng)Ginsenosides, gintonins, and polysaccharides[120]
7. Licorice (Glycyrrhiza glabra)Triterpenoids, saponin (glycyrrhetinic acid), flavonoids and sterols[121]
8. Shatavari (Asparagus racemosus)Saponins, polysaccharides, flavonoids, polyphenols, and alkaloids[122]
9. Tulsi (Ocimum sanctum)alkaloids, saponins, flavonoids, terpenoids, linoleic acid, tannins, glycosides, carbohydrates, and proteins[123]
10. Turmeric (Curcuma longa)Curcuminoids, flavonoids, phenolic acid, amino acids, and sesquiterpenes[124]
11. Andrographis (Andrographis paniculata)Andrographolide, flavonoids, neoandrographolide, andrographine, and panicolines [125]
12. Black elderberry (Sambucus nigra)Polyphenols, anthocyanins, flavonols, tannins, and procyanidins [126]
13. Cat’s claw (Uncaria tomentosa)Proanthocyanidins, spiroxindole alkaloids, quinovic acid glycosides, Indole glycosides alkaloids, and tannins[127]
14. Guduchi (Tinospora cordifolia)Alkaloids, aliphatics, diterpenoid lactones, steroids, and glycosides[128]
15. Holy basil (Ocimum tenuiflorum)Phenols, flavonoids, polyphenols, eugenol, and methylchavicol[129]
16. Milk thistle (Silybum marianum)Flavonolignans, flavonoids, tocopherol, proteins, and sterols[130]
17. Schisandra (Schisandra chinensis)Flavonoids, phenolic acids, dibenzocyclooctadiene lignans, triterpenoids, and tannins[131]
18. St. John’s wort (Hypericum perforatum)Flavonoids, naphthodianthrones (hypericin), carbolic acids, phloroglucins (hyperforin), and xanthones [132]
19. TriphalaTannins, flavonoids, gallic acid, glucosides, chebulic acid, and quercetin[133]
20. Wheatgrass (Triticum aestivum)Flavonoids, chlorophyll, tannins, terpenoids, steroids, alkaloids, and glycosides[134]
21. Myrrh Steroids, terpenoids, flavonoids, lignans, and carbohydrates[135]
22. Chamomile (Matricaria chamomilla)Flavonoids, terpenoids, sesquiterpenes, phenolic acids, and coumarins [136]
23. Ginkgo (Ginkgo biloba) Flavonoids, ginkgolides, glycosides, terpenoids, and sesquiterpenes[137]
24. Valerian (Valeriana officinalis)Flavonoids, lignans, curcuminoids, tannins, phenolic acids, and quinones[138]
25. Peppermint (Mentha piperita)Menthol, flavonoids, phenolic acids, menthone, acetaldehyde, limonene, alkaloids, saponins, and glycosides[139]
26. Saw palmetto (Serenoa repens)Fatty acids (laurate, myristate, palmitate, linoleate), and phytosterols[140]
27. Sage (Salvia officinalis)Alkaloids, fatty acids, flavonoids, tannins, steroids, terpenoids, saponins, and coumarins[141]
28. Aloe vera (Aloe vera)Flavonoids, polysaccharides, saponins, vitamins, anthraquinones, fatty acids, salicylic acid, and lignins [142]
29. Bilberry (Vaccinium myrtillus)Anthocyanins, terpenoids, flavonoids, tannins, phenolic acids, and coumarins[143]
30. Black cohosh (Actaea racemosa) Terpenoids, phenolic acids, flavonoids, alkaloids, tannins, and aromatic acids[144]
31. Feverfew (Tanacetum parthenium)Sesquiterpene lactones, flavonoids, polyenes, and volatile oils (camphor, camphene)[145]
32. Guggulu (Commiphora mukul)Terpenoids, steroids, flavonoids, gluggultetrols, lignans, polysaccharides, and amino acids[146]
33. Hawthorn (Crataegus spp.)Phenolic acids, flavonoids, pyrocatechin, terpenoids, lignans, steroids, and organic acids (fumaric, tartaric)[147]
34. Lavender (Lavandula angustifolia)Phenolic acids, flavonoids, terpenoids (hydrocarbons, oxidated), Sesquiterpenes, amino acids, aldehydes, and coumarins (coumarin, herniarin)[148]
35. Lemon balm (Melissa officinalis)Volatile compounds (neral, geraniol, citronellal, geranial), flavonoids, phenolic acids, triterpenes, and tannins[149]
36. Nettle (Urtica dioica)Flavonoids, phenolic acids, amino acids, carotenoids, organic acids (Acetic acid, citric acid, formic acid), fatty acids, and tannins[150]
37. Passion flower (Passiflora incarnata)Alkaloids, flavonoids, phenolic compounds, cyanogenic glycosides, tannins, and steroids (β-Sitosterol) [151]
38. Rhodiola (Rhodiola rosea)Phenolic compounds, flavonoids, carotenoids, vitamin E, tannins, glycosides, organic acids, and salidroside[152]
39. Slippery elm (Ulmus rubra)Polysaccharides (D-galactose, L-rhamnose, D-galacturonic acid), phytosterols, and oleic and palmitic acids[153]
40. Yarrow (Achillea millefolium)Flavonoids, phenolic acids, terpenes (guaianolides, sesquiterpenes), phytosterols, organic acids, and fatty acids[154]
41. Baikal skullcap (Scutellaria baicalensis)Flavonoids (baicalein, baicalin, wogonin), phenylethanoid glycosides, polysaccharides, steroids, phenolic compounds, amine, and organic acids[155]
42. Calendula (Calendula officinalis)Terpenoids, steroids, flavonoids, triterpeneol esters, saponins, carotenes, carbohydrates, and tocopherols[156]
43. Dandelion (Taraxacum officinale)Sesquiterpene lactones, triterpenes, sterols, flavonoids, inulin, vitamins (A, C, E, K, B), and polyphenols (hydroxycinnamic acid) [157]
44. Eleuthero (Eleutherococcus senticosus)Saponins, phenylpropanoids, phenolic acids, polysaccharides, coumarins, lignans, and provitamins[158]
45. Kava (Piper methysticum)Flavonoids (flavokavains), kavalactones, and alkaloids[159]
46. Marshmallow (Althaea officinalis)Polysaccharides, flavonoids, phytosterols, tannins, coumarins, scopoletin, and amino acids[160]
47. Red clover (Trifolium pratense)Flavonoids, saponins, clovamides, phenolic acids, coumarins, and pterocarpans[161]
48. Saw palmetto (Serenoa repens)Fatty acids (free and esterified), triterpenes, flavonoids, carotenoids, tocopherols (Ve), and phytosterols[162]
49. Wild yam (Dioscorea villosa)Steroidal saponin (Diosgenin), allantoin, polysaccharides, and alkaloids [163]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Alanazi, H.H.; Elasbali, A.M.; Alanazi, M.K.; El Azab, E.F. Medicinal Herbs: Promising Immunomodulators for the Treatment of Infectious Diseases. Molecules 2023, 28, 8045. https://doi.org/10.3390/molecules28248045

AMA Style

Alanazi HH, Elasbali AM, Alanazi MK, El Azab EF. Medicinal Herbs: Promising Immunomodulators for the Treatment of Infectious Diseases. Molecules. 2023; 28(24):8045. https://doi.org/10.3390/molecules28248045

Chicago/Turabian Style

Alanazi, Hamad H., Abdelbaset Mohamed Elasbali, Maged K. Alanazi, and Eman Fawzy El Azab. 2023. "Medicinal Herbs: Promising Immunomodulators for the Treatment of Infectious Diseases" Molecules 28, no. 24: 8045. https://doi.org/10.3390/molecules28248045

APA Style

Alanazi, H. H., Elasbali, A. M., Alanazi, M. K., & El Azab, E. F. (2023). Medicinal Herbs: Promising Immunomodulators for the Treatment of Infectious Diseases. Molecules, 28(24), 8045. https://doi.org/10.3390/molecules28248045

Article Metrics

Back to TopTop